ArriVent BioPharma Reports FY Results
ArriVent BioPharma FY23 EPS $(32.38) Vs $(28.90) YoY
Fiscal Year 2023 Financial ResultsResearch and development expenses were $64.9 million and $30.4 million for the years ended December 31, 2023 and 2022, respectively. The increase in expense was prima
Vocodia Holdings Launches AI Pilot for Energy Verification
System1, Primech Holdings, Urban-gro Among Industrial Movers
Primech Holdings Reports 1H Results
12 Industrials Stocks Moving In Thursday's Intraday Session
GainersVast Renewables (NASDAQ:VSTE) stock rose 29.9% to $3.0 during Thursday's regular session. The company's market cap stands at $89.9 million. Nauticus Robotics (NASDAQ:KITT) stock rose 17.4% to $